Ultragenyx Pharmaceutical Inc.
DE ˙ DB ˙ US90400D1081
€ 19,00 ↓ -0.11 (-0.60%)
2026-06-05
PREÇO DA AÇÃO
SecurityDE:UP0 / Ultragenyx Pharmaceutical Inc.
InstitutionGroup One Trading, L.p.
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Group One Trading, L.p. ownership in UP0 / Ultragenyx Pharmaceutical Inc.

On May 13, 2026 - Group One Trading, L.p. filed a 13F-HR form disclosing ownership of 0 shares of Ultragenyx Pharmaceutical Inc. (DE:UP0) valued at $0 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 23,208 shares of Ultragenyx Pharmaceutical Inc.. This represents a change in shares of -100.00% during the quarter. The current value of the position is $0 USD.

Group One Trading, L.p. has a history of taking positions in derivatives of the underlying security (UP0) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:UP0 / Ultragenyx Pharmaceutical Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F ULTRAGENYX PHARMACEUTICAL IN COM 90400D108 0 -23,208 -100.00 0 -100.00
2026-02-11 2025-12-31 13F ULTRAGENYX PHARMACEUTICAL IN COM 90400D108 23,208 23,208 534 0.0009
2025-11-12 2025-09-30 13F ULTRAGENYX PHARMACEUTICAL IN COM 90400D108 0 -5,559 -100.00 0 -100.00
2025-08-14 2025-06-30 13F ULTRAGENYX PHARMACEUTICAL IN COM 90400D108 5,559 5,559 202 0.0004
2025-05-14 2025-03-31 13F ULTRAGENYX PHARMACEUTICAL IN COM 90400D108 0 -3,610 -100.00 0 -100.00
2025-05-14 2024-12-31 13F/A-1 ULTRAGENYX PHARMACEUTICAL IN COM 90400D108 3,610 -6,349 -63.75 152 -72.69 0.0003
2025-02-14 2024-12-31 13F ULTRAGENYX PHARMACEUTICAL IN COM 90400D108 3,610 -6,349 152 0.0004
2024-11-14 2024-09-30 13F ULTRAGENYX PHARMACEUTICAL IN COM 90400D108 9,959 -511 -4.88 553 28.60 0.0016
2024-08-14 2024-06-30 13F ULTRAGENYX PHARMACEUTICAL IN COM 90400D108 10,470 1,335 14.61 430 0.94 0.0017
2024-05-10 2024-03-31 13F ULTRAGENYX PHARMACEUTICAL IN COM 90400D108 9,135 2,851 45.37 427 42.00 0.0016
2024-02-14 2023-12-31 13F ULTRAGENYX PHARMACEUTICAL IN COM 90400D108 6,284 591 10.38 301 48.51 0.0008
2023-11-09 2023-09-30 13F ULTRAGENYX PHARMACEUTICAL IN COM 90400D108 5,693 5,693 203 0.0007
2023-08-09 2023-06-30 13F ULTRAGENYX PHARMACEUTICAL IN COM 90400D108 0 -8,648 -100.00 0 -100.00
2023-05-12 2023-03-31 13F ULTRAGENYX PHARMACEUTICAL IN COM 90400D108 8,648 8,648 347 0.0013
2022-05-11 2022-03-31 13F ULTRAGENYX PHARMACEUTICAL IN COM 90400D108 0 -130 -100.00 0 -100.00
2022-02-11 2021-12-31 13F ULTRAGENYX PHARMACEUTICAL IN COM 90400D108 130 100 333.33 11 266.67 0.0000
2021-11-12 2021-09-30 13F ULTRAGENYX PHARMACEUTICAL IN COM 90400D108 30 -871 -96.67 3 -96.51 0.0000
2021-08-10 2021-06-30 13F ULTRAGENYX PHARMACEUTICAL IN COM 90400D108 901 804 828.87 86 681.82 0.0001
2021-05-12 2021-03-31 13F ULTRAGENYX PHARMACEUTICAL IN COM 90400D108 97 97 -89.23 11 -87.21 0.0000
2020-11-12 2020-09-30 13F ULTRAGENYX PHARMACEUTICAL IN COM 90400D108 0 -101 -100.00 0 -100.00
2020-08-13 2020-06-30 13F ULTRAGENYX PHARMACEUTICAL IN COM 90400D108 101 -1,077 -91.43 8 -84.62 0.0000
2020-05-13 2020-03-31 13F ULTRAGENYX PHARMACEUTICAL IN COM 90400D108 1,178 875 288.78 52 300.00 0.0004
2020-02-10 2019-12-31 13F ULTRAGENYX PHARMACEUTICAL IN COM 90400D108 303 251 482.69 13 550.00 0.0001
2019-11-12 2019-09-30 13F ULTRAGENYX PHARMACEUTICAL IN COM 90400D108 52 0 0.00 2 -33.33 0.0000
2019-08-09 2019-06-30 13F ULTRAGENYX PHARMACEUTICAL IN COM 90400D108 52 52 0.00 3 50.00 0.0000
2019-05-14 2019-03-31 13F/A-1 ULTRAGENYX PHARMACEUTICAL IN COM 90400D108 0 -7 -100.00 0 -100.00 0.0000
2019-02-05 2018-12-31 13F ULTRAGENYX PHARMACEUTICAL IN COM 90400D108 7 7 0 0.0000
2018-11-08 2018-09-30 13F ULTRAGENYX PHARMACEUTICAL IN COM 90400D108 0 -829 -100.00 0 -100.00
2018-08-13 2018-06-30 13F ULTRAGENYX PHARMACEUTICAL IN COM 90400D108 829 829 64 0.0005
2017-05-10 2017-03-31 13F ULTRAGENYX PHARMACEUTICAL IN COM 90400D108 0 -1,009 -100.00 0 -100.00
2017-02-15 2016-12-31 13F ULTRAGENYX PHARMACEUTICAL IN COM 90400D108 1,009 573 131.42 71 129.03 0.0007
2016-11-14 2016-09-30 13F ULTRAGENYX PHARMACEUTICAL IN COM 90400D108 436 -5,689 -92.88 31 -89.67 0.0003
2016-08-12 2016-06-30 13F ULTRAGENYX PHARMACEUTICAL IN COM 90400D108 6,125 3,151 105.95 300 59.57 0.0035
2016-05-12 2016-03-31 13F ULTRAGENYX PHARMACEUTICAL IN COM 90400D108 2,974 2,974 -51.44 188 -37.33 0.0027
2015-05-14 2015-03-31 13F ULTRAGENYX PHARMACEUTICAL IN COM 90400D108 0 -716 -100.00 0 -100.00
2015-02-11 2014-12-31 13F ULTRAGENYX PHARMACEUTICAL IN COM 90400D108 716 -439 -38.01 31 -52.31 0.0005
2014-10-31 2014-09-30 13F ULTRAGENYX PHARMACEUTICAL IN COM 90400D108 1,155 755 188.75 65 261.11 0.0010
2014-08-12 2014-06-30 13F ULTRAGENYX PHARMACEUTICAL IN COM 90400D108 400 400 18 0.0003
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-13 2026-03-31 13F ULTRAGENYX PHARMACEUTICAL IN COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2026-05-13 2026-03-31 13F ULTRAGENYX PHARMACEUTICAL IN COM Call 0 0 n/a n/a n/a
2026-05-13 2026-03-31 13F ULTRAGENYX PHARMACEUTICAL IN COM Call 0 0 n/a n/a n/a
2026-02-11 2025-12-31 13F ULTRAGENYX PHARMACEUTICAL IN COM Call 79,200 73.30 1,822 32.53 n/a n/a n/a
2025-11-12 2025-09-30 13F ULTRAGENYX PHARMACEUTICAL IN COM Call 45,700 280.83 1,375 215.14 n/a n/a n/a
2025-08-14 2025-06-30 13F ULTRAGENYX PHARMACEUTICAL IN COM Call 12,000 100.00 436 100.92 n/a n/a n/a
2025-05-14 2025-03-31 13F ULTRAGENYX PHARMACEUTICAL IN COM Call 6,000 -59.46 217 -65.11 n/a n/a n/a
2025-05-14 2024-12-31 13F/A ULTRAGENYX PHARMACEUTICAL IN COM Call 14,800 131.25 623 75.21 n/a n/a n/a
2025-02-14 2024-12-31 13F ULTRAGENYX PHARMACEUTICAL IN COM Call 14,800 623 n/a n/a n/a
2024-11-14 2024-09-30 13F ULTRAGENYX PHARMACEUTICAL IN COM Call 6,400 6,300.00 356 8,775.00 n/a n/a n/a
2024-08-14 2024-06-30 13F ULTRAGENYX PHARMACEUTICAL IN COM Call 100 -91.67 4 -92.86 n/a n/a n/a
2024-05-10 2024-03-31 13F ULTRAGENYX PHARMACEUTICAL IN COM Call 1,200 50.00 56 47.37 n/a n/a n/a
2024-02-14 2023-12-31 13F ULTRAGENYX PHARMACEUTICAL IN COM Call 800 -50.00 38 -33.33 n/a n/a n/a
2023-11-09 2023-09-30 13F ULTRAGENYX PHARMACEUTICAL IN COM Call 1,600 -65.96 57 -73.61 n/a n/a n/a
2023-08-09 2023-06-30 13F ULTRAGENYX PHARMACEUTICAL IN COM Call 4,700 217 n/a n/a n/a
2023-05-12 2023-03-31 13F ULTRAGENYX PHARMACEUTICAL IN COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2023-02-09 2022-12-31 13F ULTRAGENYX PHARMACEUTICAL IN COM Call 9,100 435.29 422 501.43 n/a n/a n/a
2022-11-09 2022-09-30 13F ULTRAGENYX PHARMACEUTICAL IN COM Call 1,700 183.33 70 94.44 n/a n/a n/a
2022-08-11 2022-06-30 13F ULTRAGENYX PHARMACEUTICAL IN COM Call 600 36 n/a n/a n/a
2022-05-11 2022-03-31 13F ULTRAGENYX PHARMACEUTICAL IN COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2022-02-11 2021-12-31 13F ULTRAGENYX PHARMACEUTICAL IN COM Call 100 8 n/a n/a n/a
2021-11-12 2021-09-30 13F ULTRAGENYX PHARMACEUTICAL IN COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-08-10 2021-06-30 13F ULTRAGENYX PHARMACEUTICAL IN COM Call 100 10 n/a n/a n/a
2021-05-12 2021-03-31 13F ULTRAGENYX PHARMACEUTICAL IN COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-02-10 2020-12-31 13F ULTRAGENYX PHARMACEUTICAL IN COM Call 100 14 n/a n/a n/a
2020-11-12 2020-09-30 13F ULTRAGENYX PHARMACEUTICAL IN COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-08-13 2020-06-30 13F ULTRAGENYX PHARMACEUTICAL IN COM Call 300 23 n/a n/a n/a
2019-08-09 2019-06-30 13F ULTRAGENYX PHARMACEUTICAL IN COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2019-05-14 2019-03-31 13F/A ULTRAGENYX PHARMACEUTICAL IN COM Call 2,500 173 n/a n/a n/a
2019-05-13 2019-03-31 13F ULTRAGENYX PHARMACEUTICAL IN COM Call 2,500 173 n/a n/a n/a
2019-02-05 2018-12-31 13F ULTRAGENYX PHARMACEUTICAL IN COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2018-11-08 2018-09-30 13F ULTRAGENYX PHARMACEUTICAL IN COM Call 12,300 623.53 939 616.79 n/a n/a n/a
2018-08-13 2018-06-30 13F ULTRAGENYX PHARMACEUTICAL IN COM Call 1,700 1,600.00 131 2,520.00 n/a n/a n/a
2018-05-16 2018-03-31 13F/A ULTRAGENYX PHARMACEUTICAL IN COM Call 100 0.00 5 0.00 n/a n/a n/a
2018-05-10 2018-03-31 13F ULTRAGENYX PHARMACEUTICAL IN COM Call 100 5 n/a n/a n/a
2018-02-09 2017-12-31 13F ULTRAGENYX PHARMACEUTICAL IN COM Call 100 0.00 5 0.00 n/a n/a n/a
2017-11-14 2017-09-30 13F ULTRAGENYX PHARMACEUTICAL IN COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2017-08-14 2017-06-30 13F ULTRAGENYX PHARMACEUTICAL IN COM Call 1,500 -50.00 93 -54.19 n/a n/a n/a
2017-05-10 2017-03-31 13F ULTRAGENYX PHARMACEUTICAL IN COM Call 3,000 -68.75 203 -69.93 n/a n/a n/a
2017-02-15 2016-12-31 13F ULTRAGENYX PHARMACEUTICAL IN COM Call 9,600 146.15 675 143.68 n/a n/a n/a
2016-11-14 2016-09-30 13F ULTRAGENYX PHARMACEUTICAL IN COM Call 3,900 3,800.00 277 5,440.00 n/a n/a n/a
2016-08-12 2016-06-30 13F ULTRAGENYX PHARMACEUTICAL IN COM Call 100 0.00 5 -16.67 n/a n/a n/a
2016-05-12 2016-03-31 13F ULTRAGENYX PHARMACEUTICAL IN COM Call 100 -97.87 6 -98.86 n/a n/a n/a
2016-02-11 2015-12-31 13F ULTRAGENYX PHARMACEUTICAL IN COM Call 4,700 42.42 527 65.72 n/a n/a n/a
2015-11-20 2015-09-30 13F/A ULTRAGENYX PHARMACEUTICAL IN COM Call 3,300 13.79 318 7.07 n/a n/a n/a
2015-11-06 2015-09-30 13F ULTRAGENYX PHARMACEUTICAL IN COM Call 3,300 318 n/a n/a n/a
2015-08-11 2015-06-30 13F ULTRAGENYX PHARMACEUTICAL IN COM Call 2,900 -66.28 297 -44.38 n/a n/a n/a
2015-05-14 2015-03-31 13F ULTRAGENYX PHARMACEUTICAL IN COM Call 8,600 437.50 534 662.86 n/a n/a n/a
2015-02-11 2014-12-31 13F ULTRAGENYX PHARMACEUTICAL IN COM Call 1,600 -38.46 70 -52.38 n/a n/a n/a
2014-10-31 2014-09-30 13F ULTRAGENYX PHARMACEUTICAL IN COM Call 2,600 147 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-13 2026-03-31 13F ULTRAGENYX PHARMACEUTICAL IN COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2026-05-13 2026-03-31 13F ULTRAGENYX PHARMACEUTICAL IN COM Put 0 0 n/a n/a n/a
2026-05-13 2026-03-31 13F ULTRAGENYX PHARMACEUTICAL IN COM Put 0 0 n/a n/a n/a
2026-02-11 2025-12-31 13F ULTRAGENYX PHARMACEUTICAL IN COM Put 49,600 376.92 1,141 265.38 n/a n/a n/a
2025-11-12 2025-09-30 13F ULTRAGENYX PHARMACEUTICAL IN COM Put 10,400 -64.38 313 -70.59 n/a n/a n/a
2025-08-14 2025-06-30 13F ULTRAGENYX PHARMACEUTICAL IN COM Put 29,200 -7.89 1,062 -7.50 n/a n/a n/a
2025-05-14 2025-03-31 13F ULTRAGENYX PHARMACEUTICAL IN COM Put 31,700 272.94 1,148 221.29 n/a n/a n/a
2025-05-14 2024-12-31 13F/A ULTRAGENYX PHARMACEUTICAL IN COM Put 8,500 -43.33 358 -57.14 n/a n/a n/a
2025-02-14 2024-12-31 13F ULTRAGENYX PHARMACEUTICAL IN COM Put 8,500 358 n/a n/a n/a
2024-11-14 2024-09-30 13F ULTRAGENYX PHARMACEUTICAL IN COM Put 15,000 0.00 833 35.23 n/a n/a n/a
2024-08-14 2024-06-30 13F ULTRAGENYX PHARMACEUTICAL IN COM Put 15,000 0.00 616 -12.00 n/a n/a n/a
2024-05-10 2024-03-31 13F ULTRAGENYX PHARMACEUTICAL IN COM Put 15,000 0.00 700 -2.37 n/a n/a n/a
2024-02-14 2023-12-31 13F ULTRAGENYX PHARMACEUTICAL IN COM Put 15,000 87.50 717 151.58 n/a n/a n/a
2023-11-09 2023-09-30 13F ULTRAGENYX PHARMACEUTICAL IN COM Put 8,000 150.00 285 93.88 n/a n/a n/a
2023-08-09 2023-06-30 13F ULTRAGENYX PHARMACEUTICAL IN COM Put 3,200 -80.25 148 -77.35 n/a n/a n/a
2023-05-12 2023-03-31 13F ULTRAGENYX PHARMACEUTICAL IN COM Put 16,200 -2.99 650 -16.04 n/a n/a n/a
2023-02-09 2022-12-31 13F ULTRAGENYX PHARMACEUTICAL IN COM Put 16,700 8,250.00 774 9,562.50 n/a n/a n/a
2022-11-09 2022-09-30 13F ULTRAGENYX PHARMACEUTICAL IN COM Put 200 8 n/a n/a n/a
2020-11-12 2020-09-30 13F ULTRAGENYX PHARMACEUTICAL IN COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2020-08-13 2020-06-30 13F ULTRAGENYX PHARMACEUTICAL IN COM Put 400 -94.44 31 -90.31 n/a n/a n/a
2020-05-13 2020-03-31 13F ULTRAGENYX PHARMACEUTICAL IN COM Put 7,200 44.00 320 49.53 n/a n/a n/a
2020-02-10 2019-12-31 13F ULTRAGENYX PHARMACEUTICAL IN COM Put 5,000 -30.56 214 -33.12 n/a n/a n/a
2019-02-05 2018-12-31 13F ULTRAGENYX PHARMACEUTICAL IN COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2018-11-08 2018-09-30 13F ULTRAGENYX PHARMACEUTICAL IN COM Put 3,000 229 n/a n/a n/a
2018-05-16 2018-03-31 13F/A ULTRAGENYX PHARMACEUTICAL IN COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2018-02-09 2017-12-31 13F ULTRAGENYX PHARMACEUTICAL IN COM Put 4,000 0.00 186 -12.68 n/a n/a n/a
2017-11-15 2017-09-30 13F ULTRAGENYX PHARMACEUTICAL IN COM Put 4,000 100.00 213 56.62 n/a n/a n/a
2017-05-10 2017-03-31 13F ULTRAGENYX PHARMACEUTICAL IN COM Put 2,000 -85.07 136 -85.56 n/a n/a n/a
2017-02-15 2016-12-31 13F ULTRAGENYX PHARMACEUTICAL IN COM Put 13,400 13,300.00 942 13,357.14 n/a n/a n/a
2016-11-14 2016-09-30 13F ULTRAGENYX PHARMACEUTICAL IN COM Put 100 -98.04 7 -97.19 n/a n/a n/a
2016-08-12 2016-06-30 13F ULTRAGENYX PHARMACEUTICAL IN COM Put 5,100 -57.14 249 -66.93 n/a n/a n/a
2016-05-12 2016-03-31 13F ULTRAGENYX PHARMACEUTICAL IN COM Put 11,900 357.69 753 157.88 n/a n/a n/a
2016-02-11 2015-12-31 13F ULTRAGENYX PHARMACEUTICAL IN COM Put 2,600 -64.38 292 -58.46 n/a n/a n/a
2015-11-20 2015-09-30 13F/A ULTRAGENYX PHARMACEUTICAL IN COM Put 7,300 -42.97 703 -46.38 n/a n/a n/a
2015-11-06 2015-09-30 13F ULTRAGENYX PHARMACEUTICAL IN COM Put 7,300 703 n/a n/a n/a
2015-08-11 2015-06-30 13F ULTRAGENYX PHARMACEUTICAL IN COM Put 12,800 68.42 1,311 177.75 n/a n/a n/a
2015-05-14 2015-03-31 13F ULTRAGENYX PHARMACEUTICAL IN COM Put 7,600 7,500.00 472 11,700.00 n/a n/a n/a
2015-02-11 2014-12-31 13F ULTRAGENYX PHARMACEUTICAL IN COM Put 100 -96.43 4 -97.47 n/a n/a n/a
2014-10-31 2014-09-30 13F ULTRAGENYX PHARMACEUTICAL IN COM Put 2,800 180.00 158 251.11 n/a n/a n/a
2014-08-12 2014-06-30 13F ULTRAGENYX PHARMACEUTICAL IN COM Put 1,000 45 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.